Answer first
For vaping products manufactured or imported for sale in Canada, the federal Nicotine Concentration in Vaping Products Regulations set a maximum nicotine concentration of 20 mg/mL. The rules also prohibit packaging and sale where the concentration displayed on the package exceeds that limit. A product brief, label, technical record and intended provincial market should be reviewed together before a commercial decision is made.1
What does the 20 mg/mL rule apply to?
Health Canada explains that the 20 mg/mL maximum applies to vaping products manufactured or imported for sale in Canada.1 The federal rules also address the nicotine concentration that appears on packaging. The product configuration, the information displayed to the market and the evidence held by the regulated party therefore need to align.
Health Canada describes vaping devices as including open systems, closed systems and disposable devices. It also notes that most devices use a battery, mouthpiece, atomizer and a chamber or reservoir; some closed systems use a disposable pre-filled cartridge or pod.2 A hardware buyer should not assume that a device category removes the need to review the applicable legal and documentation position.
A practical B2B review sequence
Use the following sequence to organize an enquiry. It is not a regulatory clearance process and does not replace qualified advice.
- Define the intended Canadian market. Record the province or territory, the commercial role of each party, and whether the product will be manufactured, imported, distributed or promoted.
- Identify the exact product configuration. Keep the device, pod or liquid specification, nicotine concentration, packaging artwork, warning treatment and market version in the same review file.
- Check the concentration and package display together. Assess the 20 mg/mL maximum and the concentration shown on packaging as a single controlled item.1
- Map labelling and packaging questions. Health Canada identifies a separate framework for labelling, packaging and, in specified circumstances, child-resistant container requirements.1
- Confirm reporting responsibilities. Manufacturers and importers in Canada may have sales and ingredient reporting duties under the Vaping Products Reporting Regulations.1
- Review promotion separately. Product documentation is not the same as promotional permission; online audience access, required information and warnings should have their own review.3
- Obtain qualified advice before release. A Canadian legal, regulatory and tax adviser should confirm current rules for the intended product, province, distribution model and advertising context.
What should be in a trade file before a quotation or purchase decision?
| Review area | Decision question | Practical record |
|---|---|---|
| Market scope | Which province or territory will the program serve? | Target-market list and distribution plan |
| Product configuration | Which device, pod, liquid and nicotine concentration are under review? | Controlled specification sheet and version identifier |
| Package information | Does the package version match the product configuration and market? | Approved artwork file and packaging review record |
| Labelling and packaging | Which federal and provincial requirements must be confirmed? | Adviser-reviewed compliance checklist |
| Reporting | Who is the manufacturer or importer for the relevant Canadian activity? | Responsibility map and reporting calendar |
| Promotion | Is the material advertising, and who can see it? | Promotion review record and audience-control assessment |
| Document ownership | Who maintains final product and regulatory records? | Document-control register and named owner |
The table is a decision-support tool, not legal advice. It is particularly important to distinguish factual product documentation from marketing material, because the latter can have different requirements.
Packaging, labelling and warnings: why a concentration check is not enough
Health Canada identifies separate frameworks for labelling and packaging, promotion, nicotine concentration and reporting.1 A trade team should not treat a 20 mg/mL check as the final compliance step. Applicable packaging and labelling requirements, including the relevant health-warning treatment, need their own review.
The current federal list incorporated by reference for vaping-product packaging includes the warning: “WARNING: Nicotine is highly addictive.”4 How a warning must appear, whether a requirement applies to a particular product, and the interaction with provincial requirements should be checked against current official regulations and qualified advice. A draft label or product render is not evidence of approval.
Advertising and online access need a separate decision
Health Canada states that the Vaping Products Promotion Regulations apply to people involved in promotion and sale, including manufacturers, importers, retailers, advertising companies and social-media influencers.3 The rules apply to advertising for vaping products and related brand elements, devices, parts and substances, whether or not the product contains nicotine.
Health Canada also says that online vaping-product advertising must be done in ways that cannot be seen or heard by young persons. The department specifically states that a simple checkbox or self-declaration of age is not sufficient verification for this purpose.3 Businesses should obtain qualified advice on whether content, imagery, audience controls, identity and age-verification measures, warnings, and provincial rules are appropriate for their particular online use.
Reporting questions for manufacturers and importers
The Vaping Products Reporting Regulations require manufacturers and importers in Canada to provide sales and ingredient information to Health Canada electronically using prescribed forms.1 Health Canada lists a Sales Report for Vaping Products, an Ingredients Report for Vaping Products, a Supplemental Ingredients Report for suppliers in specified circumstances, and a Notification of Change for vaping-product ingredients.
A trade buyer should clarify the commercial role of every entity before assuming who has reporting responsibility. The current forms can change, and Health Canada directs regulated parties to use the latest version. A responsibility map should identify the manufacturer, importer, Canadian regulatory contact, document owner and adviser before product-release planning begins.
Frequently asked questions
Is 20 mg/mL the only Canadian requirement for a vaping product?
No. The 20 mg/mL limit is one federal requirement. Labelling, packaging, promotion, reporting and provincial or territorial rules may also apply. Relevant requirements depend on the product, activity, responsible party and intended market.1
Does a product below 20 mg/mL become automatically approved for sale?
No. A concentration value below the federal maximum does not by itself establish compliance, approval, packaging suitability, reporting completion or promotional permission. Product-specific and market-specific review is still needed.
Do open, closed and disposable systems use the same checklist?
The legal review should begin with the exact product and activity, not a broad category label. Health Canada distinguishes open, closed and disposable device formats, but each program still needs a configuration, packaging, reporting and market review.2
Who should confirm a website’s age and audience controls?
A qualified Canadian legal or regulatory adviser should assess the intended online content and audience controls. Health Canada states that a simple age checkbox or self-declaration is not sufficient verification to prevent young persons from accessing online vaping-product advertising.3
Where can a trade team find current official information?
Start with Health Canada’s vaping-product regulations page and linked regulations, then obtain qualified advice for the planned product and commercial activity. Government pages and incorporated-by-reference documents can change; retain the review date and source version in the trade file.
Official sources
- Health Canada — Vaping products regulations, reviewed 22 September 2026.
- Health Canada — About vaping, last updated 4 June 2026; reviewed 22 September 2026.
- Health Canada — Vaping Products Promotion Regulations: Information Sheet, reviewed 22 September 2026.
- Health Canada — List of Health Warnings for Vaping Products, reviewed 22 September 2026.